Coloplast

Health Care Equipment
COLO-B.CO
$ 866 0.07
Share price
$ 26 bn
Market Cap
$ 30 bn
Enterprise Value

Carbon footprint

0.78 Ton
GHG emissions per $ 1 mln investment
0.03x the weighted average for S&P 500
FY2021
How is this calculated?
+8.5%
YOY change in GHG emissions
Weaker than the -8.7% weighted average for S&P 500
FY2021 vs. previous year

Primary Climate Goal

-25%
Proj. YOY change in GHG emissions (Scope 1 + 2)
Stronger than the -5.1% weighted average for S&P 500
FY2022
How is this calculated?

Coloplast aims to achieve net zero for Scope 1 + 2 by 2025


This target has not been verified as science based according to SBTi
Coloplast's actual and proj. GHG emissions (Scope 1 + 2) (Kt of CO2e)

GHG emissions and Carbon intensity

Coloplast's GHG emissions (market-based) (Kt of CO2e)
Coloplast's Carbon intensity (Tons per 1 USDm)

Coloplast's carbon footprint

Coloplast reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 30 September 2021 at 23 Kt (+1.8/+8.5% y-o-y). At the sime time, carbon intensity declined to 7.5 t (-0.4 /-5.1% y-o-y).

Coloplast's Scope 3 emissions plummeted to 131 Kt (-19 /-12.4% y-o-y). There has been no clear trend lately.

The company is committed to achieving net zero for Scope 1 + 2 by 2025, which translates into the estimated reduction of -5.8 Kt per annum over the period of FY2022 - FY2025. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.

Company environmental metrics

Show more...